RxDoctor Payments Data

Maria Maymi Soto, MD

Dermatology · Dorado, PRNPI 1144390063

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 90.2% of the total across 107 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 11 manufacturers reported payments, led by AbbVie at 48.5% of the total.

$4,240in general payments, 2019–2025

Across 107 payments — averaging $39.63 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$2K
  • Johnson & Johnson$501
  • E.r. Squibb & Sons, L.L.C.$480
  • Revance Therapeutics, Inc.$270
  • Sanofi$238
  • Genentech, Inc.$163
  • plus $532 from 5 others

What the payments were for

  • Food & beverage$3,82590%
  • Education$41510%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
AbbVie(2 entities)58$2,056
Johnson & Johnson(2 entities)17$501
E.r. Squibb & Sons, L.L.C.10$480
Revance Therapeutics, Inc.3$270
Sanofi5$238
Genentech, Inc.3$163
Janssen Scientific Affairs, LLC1$125
Genentech USA, Inc.1$125
Amgen1$125
PBG Puerto Rico LLC6$107
Pfizer2$50

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,240 in reported general payments places this provider in the 70th percentile of 108 dermatology providers in Puerto Rico.

See all dermatology providers in Puerto Rico

Medicare billing

Part B allowed, 2024
$15,148
Medicare patients
38
Services billed
328

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
TremfyaGuselkumab12$165,895
Ciclopirox406$21,509
Clobetasol Propionate300$17,017
Ketoconazole426$10,500
EucrisaCrisaborole13$9,936
Metronidazole57$7,481
Mometasone Furoate136$4,339
Tacrolimus46$3,998
Halobetasol Propionate51$3,891
Fluocinolone Acetonide Oil52$3,823
Mupirocin414$3,779
Ivermectin15$3,589
Tretinoin56$3,252
Betamethasone Valerate76$2,620
Desonide49$2,191

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Johnson & JohnsonTremfya$501$165,89512 claims
PfizerEucrisa$50$9,93613 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 70th percentile of 108 dermatology providers in Puerto Rico.

Other dermatology in Dorado

See the full list for Puerto Rico

Where these figures come from

Is this you, or does something look wrong? →